Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations
Salsabeel Sabi,Roaa Alzreqat,Ammar Almaaytah,Majed Masaadeh,Ahmad Abualhaijaa
DOI: https://doi.org/10.2147/dmso.s482056
2024-11-28
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Salsabeel H Sabi, 1 Roaa K Alzreqat, 2 Ammar M Almaaytah, 3 Majed M Masaadeh, 3 Ahmad Khaled Abualhaijaa 3 1 Basic Sciences Department, The Hashemite University, Zarqa, Jordan; 2 Department of Biological Sciences, The Hashemite University, Zarqa, Jordan; 3 Department of Pharmaceutical Technology, Jordan University of Science and Technology, Irbid, Jordan Correspondence: Salsabeel H Sabi, Email Hyperinsulinemic Hypoglycemia (HH) is a rare condition that affects newborn children in the postnatal period, represented by dangerously low levels of blood glucose in a persistent manner, which puts the baby at high risk of multiple issues, especially regarding the brain cells if the baby does not take the appropriate medication or have the correct diagnosis. Hyperinsulinemic Hypoglycemia can happen due to an active or inactive mutation in 16 genes responsible for glucose metabolism and insulin secretion ( GLUD1 , GCK , SLC16A1 , HK1 , CACNA1D , KCNJ11 , ABCC8 , FOXA2 , HNF1A , HNF4A , HADH , PGM1 , UCP2 , KCNQ1 , PMM2 , EIF2S3 ). These mutations can take place in many forms, either defused or local, affecting several or all pancreatic beta cells respectively. This review summarizes genetic variations diagnosis and treatment of Hyperinsulinemic Hypoglycemia. Keywords: Hyperinsulinemic Hypoglycemia, nesidioblastosis, GLUD1 , hexokinase , FOXA2 Hyperinsulinemic, idiopathic hypoglycemia of infancy, leucine-sensitive hypoglycemia, or nesidioblastosis are terms that refer to a rare condition characterized by immediate severe persistent Hyperinsulinemic Hypoglycemia (HH) in infants and newborn babies in the postnatal period. HH is considered a complex of disorders related to dysregulated insulin secretion. It occurs when plasma glucose levels decrease, leading cells to inappropriate insulin secretion. This leads to HH in children. 1 HH affects the neurological system in patients because it causes a decrease in blood glucose concentration, leading to a high risk of brain damage. There are different factors that lead to HH, suxh as birth asphyxia, intrauterine growth retardation, maternal diabetes mellitus, and Beckwith-Wiedemann syndrome. From this, the important diagnosis must be done to prevent some diseases like epilepsy and neuro-developmental defects. 2 The metabolism of insulin on glucose increases the neurological injury; when a human consumes a meal, it leads to glucose increases in the bloodstream, this leading to activating glucose secretion pathways that play an important role in regulating blood glucose during and after eating. While eating, the glucose level will increase above its normal range, activating the "triggering pathway" which is induced by glucose metabolism to produce Adenosine triphosphate (ATP) molecules that trigger the production of insulin by causing the ( KATP) channel to close, depolarizing the beta cells membrane, and finally activating the calcium channels to enter the calcium to beta cells and bind to insulin granules to become exocytic it to bloodstream; this pathway is known to be rapid in its response. Even some hours after eating the meal, the second "amplifying pathway" will take its place to keep managing the glucose level by secreting insulin at sustained lower rates than the "triggering pathway". Insulin stimulates lipogenesis by inhibiting free fatty acid release, β-oxidation, and ketone body formation which leads to brain injury. Although these phases aim toward the same goal, which is keeping blood glucose in a normal range all the time, they also differ in the insulin granules they trigger, the first phase "triggering phase" must be rapid so it uses the readily releasable insulin granules located on the beta cell membrane surface consuming only 1% of these granules, while on the other hand the "amplifying pathway" works hours after eating so it uses the recruited granules from the storage pool in addition to the membrane surface granules. 3 This review discusses how insulin metabolism affects the neurological system and leads to different diseases depending on different literature searches on HH using the PubMed database. It also investigates molecular and genetic mutations leading to HH, whether activating or inactivating mutation, with an example for each type. In addition it suggests ways to diagnose and treatpatients with Hyperinsulinemic Hypoglycemia. Many mutations in 16 different key genes, that are known to be responsible for regulating insulin secretion from beta-cells of the pancreas, would cause Hyperinsulinemic Hypoglycemia (HH). Multiple different syndromes are associated with Hyperinsulinem -Abstract Truncated-
endocrinology & metabolism